Iroko files for IPO

Iroko Pharmaceuticals LLC (Philadelphia, Pa.) filed to raise up to $145 million in an IPO underwritten by Jefferies; William Blair; and Canaccord. In February, FDA accepted for review an NDA for Zorvolex submicron diclofenac to treat mild to moderate acute pain in adults. In April, Iroko submitted an NDA for Tiforbex submicron indomethacin to treat acute pain in adults. ...